← All diseases
Cancer
Lung cancer (small cell)
Do you want to receive a message when there is new research about Small Cell Lung Cancer (SCLC)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication you see one sentence explaining what was studied — and you'll be notified as soon as there is new research about Small cell lung cancer. View what Premium costs.
Publications and studies (3295)
- [Mechanism of n-butanol fraction of Wenxia Formula extract in ameliorating cisplatin resistance in lung cancer via CAFs-mediated glutathione synthesis]. (2025/10/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Impact of cancer treatment on physical functioning, symptoms and health-related quality of life in patients with non-small cell lung cancer: A longitudinal observational study. (2025/10/01) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Prognostic Impact of PD-1 Polymorphisms in Non-small Cell Lung Cancer Receiving Dendritic Cell Vaccination. (2025/10/01) ♡
- Evaluation of the functional profile of bronchopulmonary cancer patients based on biomarkers in relation to the International Classification of Functioning, Disability and Health. (2025/10/01) ♡
- Subgroup Analysis of Differential Networks with Latent Variables. (2025/10/01) ♡
- Prognostic biomarkers for extensive-stage small cell lung cancer receiving amrubicin following failure of chemoimmunotherapy: a retrospective cohort study. (2025/09/30) ♡
- Multimodal prehabilitation to prevent loss of cardiorespiratory fitness in patients with locally advanced lung cancer undergoing chemoimmunotherapy: protocol for a non-randomized multicentre study. (2025/09/30) ♡
- The Prognostic Immune and Nutritional Index as a Predictor of Survival in Resected Non-Small Cell Lung Cancer. (2025/09/29) ♡
- Exploring the mechanism of Kanglixin capsules in the treatment of non-small cell lung cancer based on network pharmacology and molecular docking. (2025/09/26) ♡
- Buzhong yiqi decoction improves cisplatin resistance in non-small cell lung cancer by inhibiting PCBP1 to activate the ferritinophagy-mediated ferroptosis pathway. (2025/09/25) ♡
- Jiawei Yanghe Decoction augments intratumoral CD8(+) TIL infiltration and enhances radiotherapy efficacy in non-small cell lung cancer through CXCR3 ligand-mediated chemotaxis. (2025/09/25) ♡
- Investigating the Mechanism of Jiawei Weijin Decoction in Treating Non-Small Cell Lung Cancer Using Network Pharmacology, Bioinformatics Analysis and Experimental Validation. (2025/09/25) ♡
- Exploring acenocoumarol and silodosin in non-small cell lung cancer: Insights into EGFR-linked signaling mechanisms. (2025/09/23) ♡
- Benefit-risk evaluation of Fuzheng Yiliu Decoction combined with chemotherapy for treating non-small cell lung cancer using multicriteria decision analysis. (2025/09/23) ♡
- Dual Blockade of PI3K and EGFR Pathways by Flavonoids from Idesia polycarpa Maxim Cake Meal: Valorization of Agro-Industrial Waste for NSCLC Therapy. (2025/09/22) ♡
- Negative associations between macronutrient quality index and lung cancer incidence and mortality: results from the prostate, lung, colorectal, and ovarian cancer screening trial. (2025/09/22) ♡
- The association between acupuncture and response to immune checkpoint inhibitors in non-small cell lung cancer. (2025/09/19) ♡
- Actinidia eriantha Benth. Root as a New Phytomedicine Inhibits Non-Small Cell Lung Cancer by Regulating TGF-β/FOXO/mTOR. (2025/09/14) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Role of Reactive Oxygen Species in Lung Cancer Development: Nanomedicine as a Therapeutic Strategy. (2025/09/13) ♡
- Efficacy and safety of tislelizumab plus anlotinib and irinotecan as second-line treatment for extensive-stage small cell lung cancer: a single-arm, open-label, phase II trial. (2025/09/12) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Progress of ERK Pathway-Modulated Natural Products for Anti-Non-Small-Cell Lung Cancer Activity. (2025/09/12) ♡
- Efficacy of chemotherapy combined with immunotherapy in advanced lung adenocarcinoma harboring epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins) mutations: A retrospective comparative study. (2025/09/09) ♡
- Retracted publicationiThis research has been withdrawn by science itself, for example due to a flaw in the method or unreliable data. Do not use it as support and do not discuss it as evidence. Rare Presentation of Spontaneous Transomental Hernia in an Elderly Oncology Patient: Diagnostic Vigilance and Surgical Management. (2025/09/04) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Gegen Qinlian Tablets attenuate immune-related adverse events in NSCLC patients: A multi-center randomized controlled trial in China. (2025/09/01) ♡
- Predictive value of preoperative sarcopenia and nutritional status for postoperative complications in non-small cell lung cancer. (2025/09/01) ♡
- Prognostic value of inflammatory-nutritional indexes and HALP score in advanced stage NSCLC treated with first-line TKI. (2025/09/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Chromosomal Instability as a Driver of Therapeutic Resistance and Phenotypic Plasticity in Non-Small Cell Lung Cancer. (2025/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The microbiome and lung cancer: microbial effects on host immune responses and treatment outcomes. (2025/09/01) ♡
- Restricting glycine uptake with bitopertin improves erythropoiesis in preclinical models of Diamond-Blackfan anemia. (2025/09/01) ♡
- Development and validation of a serum inflammatory biomarker-driven machine-learning model for prognostic stratification in surgical limited-stage small cell lung cancer. (2025/08/31) ♡
- Xiaoji decoction induces apoptosis in lung cancer cells and M1 Macrophage polarization via the JAK1/STAT3/PD-L1 pathway. (2025/08/29) ♡
- Immunological and pathological characteristics of brain parenchymal and leptomeningeal metastases from non-small cell lung cancer. (2025/08/29) ♡
- RANBP9 and RANBP10 cooperate in regulating non-small cell lung cancer proliferation. (2025/08/29) ♡
- Low fT3/fT4 ratio as a proxy for muscle wasting in patients with advanced non-small cell lung cancer treated with pembrolizumab. (2025/08/27) ♡
- Risk prediction model for overall survival in lung cancer based on inflammatory and nutritional markers. (2025/08/22) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The relationship between hemoglobin, albumin, lymphocyte, and platelet score and mortality in non-small cell lung cancer. (2025/08/22) ♡
- Prognostic Role of the Naples Score in Extensive-Stage Small Cell Lung Cancer: A Missed Opportunity in Inflammation-Based Stratification. (2025/08/21) ♡
- Probing the metabolic regulator and candidate tumor suppressor ALDH1L1 as a target for non-small cell lung cancer gene therapy. (2025/08/20) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Pulmonary Squamous Cell Carcinoma With Hemopneumothorax Related to Pleuroparenchymal Fibroelastosis Post-Liver Transplantation. (2025/08/20) ♡
- Mendelian randomization identifies genetically predicted calorie dietary preference as causal risk factors for cancer. (2025/08/18) ♡
- A novel risk score for venous thromboembolism in lung cancer patients: a retrospective cohort study. (2025/08/18) ♡
- Development and validation of a nomogram for predicting 90-day mortality in patients with advanced lung cancer based on inflammatory and nutritional biomarkers. (2025/08/15) ♡
- Clinical features and risk factors of immune-mediated liver injury in non-small cell lung cancer patients treated with immune checkpoint inhibitors. (2025/08/13) ♡
- Synthesis and Biological Evaluation of β-Phenylalanine Derivatives Containing Sulphonamide and Azole Moieties as Antiproliferative Candidates in Lung Cancer Models. (2025/08/07) ♡
- YiQiChuTan formula (YQCTF) inhibit the progression of non-small cell lung cancer via down-regulating EGFR/ITGB2 signaling: Triangulated evidence from network pharmacology, proteomic profiling, and experimental validation. (2025/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Research progress on treatment of non-small cell lung cancer with traditional Chinese medicine based on immunotherapy]. (2025/08/01) ♡
- Clinical, Quality, and Cost Outcomes of Patients With Early-Stage Non-Small Cell Lung Cancer Undergoing Surgery or Stereotactic Body Radiation Therapy. (2025/07/31) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Pulmonary Artery Stent Erosion and Development of Bronchopulmonary Arterial Fistula With Massive Hemoptysis. (2025/07/30) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Effects of Bojungikki-Tang on immune response and clinical outcomes in NSCLC patients receiving immune checkpoint inhibitors: a randomized pilot study. (2025/07/29) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. ALK-Positive Lung Adenocarcinoma With Suspected Transformation to Squamous Cell Carcinoma in Lymph Node Metastases. (2025/07/29) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.